Sonnet BioTherapeutics Holdings, Inc. Recorded Big Gain

Tue, Aug 31, 2021 at 05:33 PM
Sonnet BioTherapeutics Holdings, Inc. Recorded Big Gain

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) shot up at $0.69, representing a gain of 23.4%. On Mon, Aug 30, 2021, SONN:NASDAQ hit a New 2-Week Low of $0.56. The stock appeared on our News Catalysts scanner on Mon, Aug 30, 2021 at 05:01 PM in the 'BIOTECH' category. From Mon, Aug 16, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days

The stock spiked on Thu, Aug 19, 2021 at $2.07 with a volume of 20B+.

About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.